Saudi Chemical Holding Company

2230.SR · Healthcare · · SAR

8.24 SAR

+0.00 (1.10%)

● Updated 2026-09-07 20:30 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

/ 100

Technical 100

Trend & RS 76

Momentum 58

Fundamental 56

Macro 59

Liquidity 53

Component	Score	Weight
Technical	100.0	20%
Trend & RS	76.3	30%
Momentum	57.7	15%
Fundamental	55.6	10%
Macro	59.4	20%
Liquidity	52.9	5%

Trade Setup

Entry	8.24
Stop Loss	7.90 (4.1%)
Target 1 (1:1)	8.58 (+4.1%)
Target 2 (2:1)	8.92 (+8.2%)

ATR(14)	0.17 (2.1%)
Risk per Share	0.34
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	71.6	+0.86
Momentum	57.7	+0.31
Quality	35.0	-0.60
Composite	54.7

Quality Scores

Piotroski F-Score 5 /9 — Average

✓ ✓ ✗ ✗ ✓ ✗ ✓ ✓ ✗

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	19.6	22.0	-11% below
P/B Ratio	2.8	4.0	Below
Dividend Yield	1.2%	1.5%	Below avg

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

4.96

Market Price

8.24

Upside

-39.9%

Margin of Safety	-66.3%
Stage 1 PV (5yr FCF)	1,210,998,400
Terminal Value PV	2,967,499,083
Total Enterprise Value	4,178,497,483

Assumptions

Base FCF	283,315,200
Growth Rate (5yr)	4.3%
Terminal Growth	2.5%
Discount Rate (WACC)	10.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

46.7%

Full Kelly

23.35%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 72/100. Estimated win rate 61%, avg win 9.3%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

59.71

RSI(14)

-0.0097

MACD

Relative Strength (RS) NEUTRAL

/ 99

RS Rating

O'Neil filter: <80

RS vs TASI	→ FLAT (+0.1% vs TASI 3M)
RS vs Sector	UNDERPERFORMING (Healthcare)
RS New High	No (60d since high)
Sector Outperformance	-7.5% (3M)

RS Line — stock / TASI (90 bars)

← older newer →

RS vs TASI 50-day SMA of RS

NEUTRAL: In line with the market — no strong outperformance or underperformance.

Technical Indicators

Indicator	Value	Signal
Rsi	59.71	NEUTRAL
Macd	-0.0097	BULLISH
Ma Cross	8.13 / 7.74	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	1.22x	NORMAL

Key Levels

Level	Price
52-Week High	8.98
Bollinger Upper	8.26
SMA(200)	7.74
SMA(50)	8.13
SMA(20)	7.98
Current Price	8.24
Bollinger Lower	7.7
52-Week Low	6.06
ATR(14)	0.17

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION E Confidence

50%

Acc: 1.0 | Dist: 1.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-09-01	Normal	3.9x	Normal bar — no special VSA pattern
2026-09-02	Normal	1.91x	Normal bar — no special VSA pattern
2026-09-03	Normal	1.09x	Normal bar — no special VSA pattern
2026-09-06	Normal	1.09x	Normal bar — no special VSA pattern
2026-09-07	Normal	1.22x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	8.00	Below Kijun
Kijun-sen (26)	8.04	Base line
Senkou A	8.02	Leading span A
Senkou B	8.14	Leading span B
Cloud	8.02 – 8.14	Bearish (Red)
Price vs Cloud	8.24	Above Cloud
Chikou Span	8.13	Bullish
Alignment Score	2/4	NEUTRAL